CAS 376348-77-5: 4,4-Difluoro-N-[(1S)-3-hydroxy-1-phenylpropyl]cyclohexanecarboxamide
Fórmula:C16H21F2NO2
InChI:InChI=1S/C16H21F2NO2/c17-16(18)9-6-13(7-10-16)15(21)19-14(8-11-20)12-4-2-1-3-5-12/h1-5,13-14,20H,6-11H2,(H,19,21)/t14-/m0/s1
Chave InChI:InChIKey=OOIJZFMUKIGIRX-AWEZNQCLSA-N
SMILES:O=C(NC(C=1C=CC=CC1)CCO)C2CCC(F)(F)CC2
- Sinónimos:
- Cyclohexanecarboxamide, 4,4-difluoro-N-[(1S)-3-hydroxy-1-phenylpropyl]-
- 4,4-Difluoro-N-[(1S)-3-hydroxy-1-phenylpropyl]cyclohexanecarboxamide
- UK 453465
- (S)-4,4-Difluoro-N-(3-hydroxy-1-phenylpropyl)cyclohexanecarboxamide
- 4,4-Difluoro-N-((1S)-3-hydroxy-1-phenylpropyl)cyclohexanecarboxamide
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
![]() | Maraviroc Impurity 2 REF: 4Z-M-586CAS: 376348-77-5 | - - - | A consultar | Ter 11 Mar 25 |
![]() | 4,4-Difluoro-N-[(1S)-3-hydroxy-1-phenylpropyl]-cyclohexanecarboxamide REF: TR-D446073CAS: 376348-77-5 | - - - | 92,00 €~247,00 € | Seg 14 Abr 25 |
![]() | 4,4-Difluoro-N-((1S)-3-hydroxy-1-phenylpropyl)cyclohexanecarboxamide REF: 3D-FD100355CAS: 376348-77-5 | Min. 95% | - - - | Produto descontinuado |

Ref: 4Z-M-586
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |

4,4-Difluoro-N-[(1S)-3-hydroxy-1-phenylpropyl]-cyclohexanecarboxamide
Produto ControladoRef: TR-D446073
10mg | 92,00 € | ||
25mg | 178,00 € | ||
50mg | 247,00 € |

4,4-Difluoro-N-((1S)-3-hydroxy-1-phenylpropyl)cyclohexanecarboxamide
Ref: 3D-FD100355
5mg | Descontinuado | Solicitar informações | |
10mg | Descontinuado | Solicitar informações | |
25mg | Descontinuado | Solicitar informações |